OBJECTIVES: To assess the value of dual-energy contrast-enhanced computed tomography (CT) imaging for the detection of urinary stone disease using dual-source CT. MATERIALS AND METHODS: Forty consecutive patients (mean age 46.6 +/- 16.2 years, range 27-85 years) suspected of having urinary stone disease underwent dual-source CT of the urinary tract. A 3-phasic CT scan protocol consisting of a standard unenhanced scan, a nephrographic, and an excretory phase of contrast enhancement was performed. The nephrographic phase scan was acquired in the dual-energy mode (80 kV/400 mA and 140 kV/95 mA) allowing reconstruction of virtual unenhanced images. Two blinded readers independently compared standard and virtual unenhanced CT for the number, size, and location of urinary stones. Measurements of anteroposterior abdominal diameters were performed to determine abdominal obesity. RESULTS: Standard unenhanced CT revealed 35 uroliths in 18 of the 40 patients (18 of 40; 45%), virtual unenhanced CT demonstrated 26 uroliths in 15 of the 40 patients (15 of 40; 38%) ([kappa] value 0.89). Three false-negative and no false-positive ratings occurred using virtual unenhanced CT, and false-negative ratings solely occurred in obese patients. Sensitivity, specificity, positive predictive, and negative predictive values for virtual unenhanced CT for the diagnosis of urinary stone disease were 83%, 100%, 100%, and 88%, respectively. CONCLUSIONS: Virtual unenhanced CT images reconstructed from contrast-enhanced dual-energy CT allow detection of urinary stones with good sensitivity and excellent specificity, but sensitivity is decreased in abdominal obese patients.
OBJECTIVES: To assess the value of dual-energy contrast-enhanced computed tomography (CT) imaging for the detection of urinary stone disease using dual-source CT. MATERIALS AND METHODS: Forty consecutive patients (mean age 46.6 +/- 16.2 years, range 27-85 years) suspected of having urinary stone disease underwent dual-source CT of the urinary tract. A 3-phasic CT scan protocol consisting of a standard unenhanced scan, a nephrographic, and an excretory phase of contrast enhancement was performed. The nephrographic phase scan was acquired in the dual-energy mode (80 kV/400 mA and 140 kV/95 mA) allowing reconstruction of virtual unenhanced images. Two blinded readers independently compared standard and virtual unenhanced CT for the number, size, and location of urinary stones. Measurements of anteroposterior abdominal diameters were performed to determine abdominal obesity. RESULTS: Standard unenhanced CT revealed 35 uroliths in 18 of the 40 patients (18 of 40; 45%), virtual unenhanced CT demonstrated 26 uroliths in 15 of the 40 patients (15 of 40; 38%) ([kappa] value 0.89). Three false-negative and no false-positive ratings occurred using virtual unenhanced CT, and false-negative ratings solely occurred in obesepatients. Sensitivity, specificity, positive predictive, and negative predictive values for virtual unenhanced CT for the diagnosis of urinary stone disease were 83%, 100%, 100%, and 88%, respectively. CONCLUSIONS: Virtual unenhanced CT images reconstructed from contrast-enhanced dual-energy CT allow detection of urinary stones with good sensitivity and excellent specificity, but sensitivity is decreased in abdominal obesepatients.
Authors: C N De Cecco; V Buffa; S Fedeli; A Vallone; R Ruopoli; M Luzietti; V Miele; M Rengo; M Maurizi Enrici; P Fina; A Laghi; V David Journal: Radiol Med Date: 2010-09-17 Impact factor: 3.469
Authors: Christoph Karlo; Arno Lauber; Robert Paul Götti; Stephan Baumüller; Paul Stolzmann; Hans Scheffel; Lotus Desbiolles; Bernhard Schmidt; Borut Marincek; Hatem Alkadhi; Sebastian Leschka Journal: Eur Radiol Date: 2010-08-15 Impact factor: 5.315
Authors: Lifeng Yu; Xin Liu; Shuai Leng; James M Kofler; Juan C Ramirez-Giraldo; Mingliang Qu; Jodie Christner; Joel G Fletcher; Cynthia H McCollough Journal: Imaging Med Date: 2009-10
Authors: C L Brown; R P Hartman; O P Dzyubak; N Takahashi; A Kawashima; C H McCollough; M R Bruesewitz; A M Primak; J G Fletcher Journal: Eur Radiol Date: 2009-01-20 Impact factor: 5.315